Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab

NCT01543204 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
64
Enrollment
INDUSTRY
Sponsor class

Stopped Business decision due to slow enrollment

Conditions

Interventions

Sponsor

Amgen